Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial)

BACKGROUND: Ivermectin is being considered for mass drug administration for malaria, due to its ability to kill mosquitoes feeding on recently treated individuals. In a recent trial, 3-day courses of 300 and 600 mcg/kg/day were shown to kill Anopheles mosquitoes for at least 28 days post-treatment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Smit, Menno R, Ochomo, Eric O, Aljayyoussi, Ghaith, Kwambai, Titus K, Abong’o, Bernard O, Bousema, Teun, Waterhouse, David, Bayoh, Nabie M, Gimnig, John E, Samuels, Aaron M, Desai, Meghna R, Phillips-Howard, Penelope A, Kariuki, Simon K, Wang, Duolao, Ward, Stephen A, ter Kuile, Feiko O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743833/
https://www.ncbi.nlm.nih.gov/pubmed/30590537
http://dx.doi.org/10.1093/cid/ciy1063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743833/
https://www.ncbi.nlm.nih.gov/pubmed/30590537
http://dx.doi.org/10.1093/cid/ciy1063

Ejemplares similares